DIRECT BLOOD ASSAY FOR DETECTION OF CIRCULATING MICRORNA IN CANCER PATIENTS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 5, 2013
app pub date -
Mar 22, 2013
filing date -
Sep 22, 2010
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Methods of diagnosing, determining the progression, or determining a prognosis of a cancer in a subject are provided. Such methods may include steps of measuring a test level of one or more miR molecules in a biological sample from the subject; comparing the test level to a control level of the one or more miR molecules; and diagnosing a subject as having a cancer, differentiating between a locoregional cancer and a cancer that has progressed to a cancer with visceral or distant metastasis, or determining a prognosis for the subject having a cancer when the test level is significantly different than the control level.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully